alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Research

27,380 Alzheimer's and dementia studies in plain English, each scored out of 100.

Find studies

Showing 9,451–9,475 of 10,985 studies · free to read (page 379 of 440) · 27,380 in the whole library · How the 0–100 score works

Download bibliography of the first 500 of these studies, in this order: BibTeX (.bib) · RIS (.ris)

Browse by subject, author or institution

Each number is how many studies that link shows, with your other filters kept.

Subjects

Authors

Names as each record prints them; the same person can appear under two spellings.

Institutions

From OpenAlex; 12,859 studies have no institution on record and are not counted here.

A note on reading research. One study is rarely the final word.

We try to note the size of a study, whether it was in humans or animals, and how early-stage the finding is. If a summary here doesn't make that clear, treat it with extra caution and check the original source.

Causality between Alzheimer disease and delirium: A two-sample Mendelian randomization study and gene colocalization analyses

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Medicine 2026-01-30

To evaluate the possible causality between Alzheimer disease (AD) and delirium, a two-sample Mendelian randomization (MR) method and gene colocalization strategy were employed. 4 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Real-world safety profile of lecanemab: A disproportionality analysis of adverse events in the FDA adverse event reporting system

✓ Peer-reviewed alzhub usefulness score 38 out of 100. JAPhA Pharmacotherapy 2025-04-01

This study underscores the importance of vigilant monitoring for ARIA and other neurologic and psychiatric AEs associated with lecanemab in real-world clinical settings. 4 key findings →

Participants: 1,307,937 Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Transport pathways across the blood-brain barrier for waste clearance and drug delivery

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Fluids and Barriers of the CNS 2026-05-16

The blood-brain barrier (BBB) displays a highly organized and complex structure, which is important for maintaining brain homeostasis and protecting the brain from foreign molecules or pathogens. 5 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Risk Governance for the Implementation of the Sendai Framework for Disaster Risk Reduction in Algeria

✓ Peer-reviewed alzhub usefulness score 38 out of 100. International Journal of Disaster Risk Science 2025-01-22

These disasters, along with other endogenous causes not addressed in this article, have significantly hindered the country’s progress toward key global objectives, including the SFDRR. 1 key finding →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Precision prevention in exercise: Integrating OMICS biomarkers and artificial intelligence for injury risk assessment

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Advanced Exercise and Health Science 2025-10-04

Exercise injuries present a significant challenge in medicine and public health, impacting exercise performance, career longevity, and overall quality of life. 3 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Socially inclusive infrastructure for disaster risk reduction in urban planning: insights from the SADC region

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Frontiers in Built Environment 2025-05-16

In response to these challenges, the study recommends a paradigm shift in urban planning towards the adoption of future-oriented and participatory approaches. 1 key finding →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Cardiovascular Disease Management and Prevention in Saudi Arabia: Strategies, Risk Factors, and Targeted Interventions

✓ Peer-reviewed alzhub usefulness score 38 out of 100. International Journal of Clinical Practice 2025-01-01

Cardiovascular diseases (CVDs) remain the main cause of mortality and are generally among the leading causes of morbidity worldwide, thus placing an immense burden on health care. 5 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

The significance of a dementia diagnosis from the perspective of the family caregivers: a qualitative study

✓ Peer-reviewed alzhub usefulness score 38 out of 100. BMC Health Services Research 2025-04-02

Three main categories were created: (1) Impact of observed cognitive decline, (2) Impact of diagnosis on service engagement, and (3) Support and follow-up for family caregivers. 5 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Prevalence, aetiology, and service mapping of dementia in rural Uganda. Part of DEPEND Uganda (Dementia Epidemiology, unmet Need and co-Developing Solutions in Uganda)

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Wellcome Open Research 2025-01-24

This is the first study in Africa using blood-based and retinal imaging biomarkers to examine pathological processes underlying dementia, and systematically map services available for people with dementia. 5 key findings →

Evidence: moderate

Full summary, score breakdown and related studies → Original source Free full text

Evaluation of AccuBrain-based MRI quantitative analysis in diagnosing Alzheimer’s disease and assessing behavioral and psychological symptoms of dementia

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Aging Clinical and Experimental Research 2025-04-17

AD patients had significantly higher AD-RAI (0.91 ± 0.25) and more pronounced hippocampal atrophy (0.36 ± 0.09) compared to MCI and HC (P 0.9 for distinguishing BPSD from non-BPSD patients. 3 key findings →

Participants: 40 Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Assessing Cognitive Impairment in the Health and Retirement Study Harmonized Cognitive Assessment Protocol Project: Comparing a Diagnostic Algorithm With a Diagnostic Consensus Panel

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of Aging and Health 2025-04-15

BackgroundAccurate classification of cognitive impairment in population studies is challenging. 3 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Muti-band Morlet mutual information functional connectivity for classifying Alzheimer's disease and frontotemporal dementia with a deep learning technique

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Computers in Biology and Medicine 2025-09-05

Accurate differentiation of Alzheimer's disease (AD), frontotemporal dementia (FTD), and healthy control (HC) is critical for early diagnosis and intervention of brain disorders. 1 key finding →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Prevalence of Post-stroke Cognitive Impairment and Dementia in a Sudanese Cohort: A Single-center Retrospective Study

✓ Peer-reviewed alzhub usefulness score 38 out of 100. International Journal of Biochemistry Research & Review 2025-02-07

Of 81 stroke survivors (mean age 61.9±13.9 years), 72.8% had ischemic stroke, and 27.2% had hemorrhagic stroke. 5 key findings →

Design: cross-sectional Evidence: moderate

Full summary, score breakdown and related studies → Original source Free full text

Classifying mild cognitive impairment from normal cognition: fMRI complexity matches tau PET performance

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring 2025-07-01

The fMRI entropy classifier matched the tau PET model in accuracy and outperformed it in F1 score (0.64 vs. 0.61) and area under the curve (AUC; 0.73 vs. 0.67). 4 key findings →

Evidence: moderate

Full summary, score breakdown and related studies → Original source Free full text

Alzheimer-typical temporo-parietal atrophy and hypoperfusion are associated with a more significant cholinergic impairment in amnestic neurodegenerative syndromes

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of Alzheimer s Disease 2025-03-21

BackgroundTo date, cholinomimetics remain central in the pharmacotherapy of Alzheimer's disease (AD) dementia. 2 key findings →

Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

Trust, consistency and transparency: in-home respite needs and preferences of people living with dementia and their carers

✓ Peer-reviewed alzhub usefulness score 38 out of 100. Frontiers in Health Services 2025-07-08

This exploratory, interpretivist, pre-implementation qualitative study used semi-structured interviews with 15 participants—four people living with dementia and 11 carers—to identify their needs, preferences, and perspectives to inform the design and implementation of an in-home respite service. 5 key findings →

Participants: 15 Evidence: low

Full summary, score breakdown and related studies → Original source Free full text

↑ Change the filters

Where “Free full text” comes from

Free full text links and the Full text may need a subscription label come from Unpaywall, Europe PMC and OpenAlex records of free copies, checked 10 Oct 2026. A study with neither is unknown, not paywalled.

How the 0–100 score works — and why some entries are capped

This is alzhub's own score. It is not an official metric, not an impact factor, and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a scientist can tell a landmark trial from a conference abstract without having to already know the difference. Every point comes from one of 20 components, all of them printed on the study itself, so you can disagree with our arithmetic rather than having to trust the total.

  • Journal tier up to 10 pts
  • Journal's citation record up to 4 pts
  • Study design up to 12 pts
  • Strength of evidence up to 5 pts
  • Peer-review validation up to 10 pts
  • How recent up to 5 pts
  • Sample size up to 4 pts
  • Effect reported up to 3 pts
  • Studied in people up to 3 pts
  • Randomised / blinded up to 2 pts
  • Times cited up to 7 pts
  • Citations per year up to 5 pts
  • Impact for its field and year up to 6 pts
  • Cited by studies here up to 6 pts
  • Still being cited up to 4 pts
  • Senior author's track record up to 4 pts
  • Institution's track record up to 3 pts
  • Multi-centre collaboration up to 3 pts
  • Indexed in PubMed up to 2 pts
  • Free to read up to 2 pts

Journals are placed in ordered tiers, never given a numeric impact factor — we could not verify current impact factors from a source we control, and an invented one would be worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science, Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed journal. A separate part scores how much the journal's own papers are cited, which tells the tier-3 journals apart.

Two rules we don't bend. First, we never fill in a missing value: if a record does not state a sample size or a design, that component scores zero, and if we simply have no data for a part, such as a citation count, that part is left out and the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed article is capped at 16/100 and carries a warning chip — so a conference abstract or a company press release can never outrank a peer-reviewed paper, no matter how good it looks.

We rank a rigorous null result — a good trial showing that something does not work — above an early positive finding. Someone deciding whether to buy a supplement is served by that, and the rigour is already counted by the design and journal components.

The score is computed from the published data alone and is reproducible: the same file always yields the same numbers.

See the whole rubric drawn out → — four charts covering all 27,380 studies: how the scores are spread and where the cap bites, which of the 20 components the library is strong and weak on, which subjects rest on stronger evidence, and what kinds of study each subject is actually built from.

What this library is — and isn't

This is a large sample of the Alzheimer's literature, not an exhaustive index of it. It holds 27,380 records, built mostly from automated pulls of Europe PMC (60.6% of the library) and OpenAlex (18.6%), plus smaller pulls from PubMed, Crossref and medRxiv. If a study, a drug, or a finding isn't here, that is not evidence it doesn't exist in the literature — it may simply not have been pulled in yet.

1,032 records (3.8% of the library) are not peer-reviewed — 962 of those are preprints posted before any journal review, and the rest are conference abstracts, regulatory notices and reports. Every study card on this page states its status plainly, and the score above is capped for anything that isn't a peer-reviewed article.

See the full, machine-readable breakdown of this library's coverage →

Newest studies, as a dated timeline →    Atom feed